RecruitingNCT06019975

FDG-PET in the Diagnosis of Autoimmune Encephalitis

Sponsor

University of Milano Bicocca

Enrollment

90 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Autoimmune Encephalitis

Summary

The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is: •is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying FDG-PET for people with autoimmune encephalitis. The study is currently recruiting participants at 6 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.